NYSE : PHR
Phreesia, Inc. — Key statistics
Healthcare · Health Information Services · United States
Last price 12.44 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 772.16M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 772.16M |
| Enterprise Value | 767.16M |
Dates
| Measure | Value |
|---|
| Earnings Date | Dec 7, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 62.07M |
| Shares Outstanding | 62.07M |
| Shares Change (YoY) | +7.36% |
| Shares Change (QoQ) | +0.68% |
| Owned by Insiders (%) | 6.29% |
| Owned by Institutions (%) | 85.12% |
| Float | 49.23M |
Ratios
| Measure | Value |
|---|
| PE Ratio | 72.42 |
| Forward PE | 21.27 |
| PS Ratio | 1.52 |
| Forward PS | 1.48 |
| PB Ratio | 2.08 |
| P/TBV Ratio | 10.76 |
| P/FCF Ratio | 9.56 |
| P/OCF Ratio | 8.45 |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 73.43 |
| EV / Sales | 1.51 |
| EV / EBITDA | 17.53 |
| EV / EBIT | 35.25 |
| EV / FCF | 9.50 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 1.76 |
| Quick Ratio | 1.44 |
| Debt / Equity | 0.18 |
| Debt / EBITDA | 1.51 |
| Debt / FCF | 0.84 |
| Interest Coverage | 2.14 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 3.12% |
| Return on Assets (ROA) | 2.58% |
| Return on Invested Capital (ROIC) | 3.62% |
| Return on Capital Employed (ROCE) | 4.33% |
| Weighted Average Cost of Capital (WACC) | 9.13% |
| Revenue Per Employee | $283,842 |
| Profits Per Employee | $5,840 |
| Employee Count | 1,789 |
| Asset Turnover | 0.96 |
| Inventory Turnover | n/a |
Taxes
| Measure | Value |
|---|
| Income Tax | -7.68M |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.84 |
| 52-Week Price Change | -46.43% |
| 50-Day Moving Average | 11.04 |
| 200-Day Moving Average | 10.92 |
| Relative Strength Index (RSI) | 66.98 |
| Average Volume (20 Days) | 666,064 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 3.08M |
| Short Previous Month | 3.11M |
| Short % of Shares Out | 4.96% |
| Short % of Float | 6.25% |
| Short Ratio (days to cover) | 4.49 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 507.79M |
| Gross Profit | 342.86M |
| Operating Income | 21.76M |
| Pretax Income | 2.76M |
| Net Income | 10.45M |
| EBITDA | 43.76M |
| EBIT | 21.76M |
| Earnings Per Share (EPS) | $0.17 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 72.95M |
| Total Debt | 67.95M |
| Net Cash | 5.00M |
| Net Cash Per Share | $0.08 |
| Equity (Book Value) | 371.85M |
| Book Value Per Share | 5.99 |
| Working Capital | 109.67M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 91.38M |
| Capital Expenditures | -10.63M |
| Depreciation & Amortization | 22.00M |
| Net Borrowing | 53.53M |
| Free Cash Flow | 80.75M |
| FCF Per Share | $1.30 |
Margins
| Measure | Value |
|---|
| Gross Margin | 67.52% |
| Operating Margin | 4.29% |
| Pretax Margin | 0.54% |
| Profit Margin | 2.06% |
| EBITDA Margin | 8.62% |
| EBIT Margin | 4.29% |
| FCF Margin | 15.90% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -7.36% |
| Shareholder Yield | -7.36% |
| Earnings Yield | 1.38% |
| FCF Yield | 10.46% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $13.93 |
| Price Target Difference | 11.98% |
| Analyst Consensus | Buy |
| Analyst Count | 18 |
| Revenue Growth Forecast (3Y) | 5.14% |
| EPS Growth Forecast (3Y) | 9.03% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 1.51 |
| Piotroski F-Score | 4 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside | |